Results 161 to 170 of about 9,525 (211)
Some of the next articles are maybe not open access.
Catharanthus Alkaloids XXVI: Isolation of Cathanneine, a New Alkaloid from Catharanthus lanceus
Journal of Pharmaceutical Sciences, 1972A new dihydroindole alkaloid, having the composition C24H30N2O5, was isolated from the leaf (A) fraction of Catharanthus lanceus. The isolation procedure and physical characterization of this new base, named cathanneine, are described.
G, Aynilian +3 more
openaire +2 more sources
Antiviral Activity of Selected Catharanthus Alkaloids
Journal of Pharmaceutical Sciences, 1968Thirty-six alkaloids isolated either from Catharanthus roseus or C. lanceus were evaluated for in vitro activity against vaccinia and polio type III viruses. Nine of these alkaloids were effective as antiviral agents, with pericalline being the most effective.
N R, Farnsworth +2 more
openaire +2 more sources
Codon usage bias of Catharanthus roseus
China Journal of Chinese Materia Medica, 2016This study aimed to provide guidance for the heterogenous gene expression, gene prediction and species evolution by analyzing codon usage bias of Catharanthus roseus.The codon composition and usage bias of 30 437 high-confidence coding sequences from C.roseus were analyzed and the proportion of rare codons of Escherichia coli and Saccharomyces ...
Ying, Li +4 more
openaire +2 more sources
Transformation in Catharanthus Species (Madagascar Periwinkle)
1993Secondary metabolite production by plant cell cultures has been the subject of many investigations. Indole alkaloids such as ajmalicine, an antihypertensive drug, or vinblastine and vincristin, two antitumor compounds produced by Catharanthus roseus, are very important in the pharmaceutical industry.
David, C., Tempe, J.
openaire +2 more sources
[Pharmacology of Catharanthus alkaloids].
Bulletin du cancer, 1996Catharanthus alkaloids are antitumoral drugs widely used in the treatment of malignant diseases. This review summarizes different aspects of their pharmacology (mechanism of action, resistance, clinical pharmacokinetics) as well as information on their uses in the clinical setting.
D, Levêque, J, Wihlm, F, Jehl
openaire +1 more source